Bellevue Group’s SI-BONE Inc SIBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-90,331
Closed -$1.78M 189
2025
Q4
$1.78M Sell
90,331
-208,526
-70% -$3.62M 0.03% 100
2025
Q3
$4.4M Sell
298,857
-241,255
-45% -$3.94M 0.09% 78
2025
Q2
$10.2M Sell
540,112
-332,879
-38% -$5.52M 0.22% 63
2025
Q1
$12.2M Sell
872,991
-7,988
-0.9% -$129K 0.27% 66
2024
Q4
$12.4M Sell
880,979
-563,130
-39% -$7.58M 0.24% 75
2024
Q3
$20.2M Buy
1,444,109
+56,500
+4% +$850K 0.33% 72
2024
Q2
$17.9M Buy
1,387,609
+247,653
+22% +$3.54M 0.29% 79
2024
Q1
$18.7M Buy
1,139,956
+1,014,756
+811% +$19.1M 0.28% 79
2023
Q4
$2.63M Buy
+125,200
New +$2.32M 0.04% 103

Other funds holding SIBN

Bellevue Group's SIBN Position: Q1 2026 in Review

Bellevue Group sold out of SI-BONE Inc (SIBN) in Q1 2026, closing a stake of 90,331 shares — an estimated $1.78M sold.

Bellevue Group first reported a position in SIBN in Q4 2023 and held it in 9 quarters. The position peaked at $20.2M in Q3 2024. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

  • Bellevue Group reported no remaining SI-BONE Inc position as of Q1 2026 after selling out during the quarter.
  • Bellevue Group sold 90,331 SI-BONE Inc shares in Q1 2026, an estimated $1.78M.
  • Bellevue Group first reported a position in SI-BONE Inc in Q4 2023 and held it in 9 quarters.
  • Bellevue Group's SI-BONE Inc position peaked at $20.2M in Q3 2024.
  • 180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.